AVX Pharma Overview
Founded
2013
Status
Acquired/Merged
Latest Deal Type
M&A
Financing Rounds
4
AVX Pharma General Information
Description
Developer of medicinal drugs designed to offer treatment for ophthalmic diseases. The company's drugs focuses on ocular surface diseases by providing advanced medicinal products, enabling patients to recover faster from dry eye syndrome.
Contact Information
Website
Formerly Known As
Avizorex Pharma
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
Primary Office
- Parc Científic de Barcelona
- C/Baldiri Reixac 4-8, Torre R
- 08028 Barcelona
- Spain
AVX Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore AVX Pharma‘s full profile, request access.
Request a free trial
AVX Pharma Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore AVX Pharma‘s full profile, request access.
Request a free trial